Cargando…

Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care

Drug-resistant TB (DR-TB) remains a significant challenge in TB treatment and control programmes worldwide. Advances in sequencing technology have significantly increased our understanding of the mechanisms of resistance to anti-TB drugs. This review provides an update on advances in our understandi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dookie, Navisha, Rambaran, Santhuri, Padayatchi, Nesri, Mahomed, Sharana, Naidoo, Kogieleum
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909630/ https://www.ncbi.nlm.nih.gov/pubmed/29360989 http://dx.doi.org/10.1093/jac/dkx506

Ejemplares similares

Mycobacterium tuberculosis Intra-Host Evolution Among Drug-Resistant Tuberculosis Patients Failing Treatment
por: Perumal, Rubeshan, et al.
Publicado: (2023)

Application of Next Generation Sequencing for Diagnosis and Clinical Management of Drug-Resistant Tuberculosis: Updates on Recent Developments in the Field
por: Dookie, Navisha, et al.
Publicado: (2022)

Individualized Treatment of Multidrug-resistant Tuberculosis Using Whole-Genome Sequencing and Expanded Drug-Susceptibility Testing
por: Dookie, Navisha, et al.
Publicado: (2020)

Higher plasma interleukin − 6 levels are associated with lung cavitation in drug-resistant tuberculosis
por: Maseko, Thando Glory, et al.
Publicado: (2023)

Recurrent tuberculosis among HIV-coinfected patients: a case series from KwaZulu-Natal
por: Naidoo, Kogieleum, et al.
Publicado: (2018)

Isoniazid resistance-conferring mutations are associated with highly variable phenotypic resistance
por: Lale Ngema, Senamile, et al.
Publicado: (2023)

Blood monocyte and dendritic cell profiles among people living with HIV with Mycobacterium tuberculosis co-infection
por: Rambaran, Santhuri, et al.
Publicado: (2023)

Effect of Inflammatory Cytokines/Chemokines on Pulmonary Tuberculosis Culture Conversion and Disease Severity in HIV-Infected and -Uninfected Individuals From South Africa
por: Rambaran, Santhuri, et al.
Publicado: (2021)

NK cell phenotypic profile during active TB in people living with HIV-evolution during TB treatment and implications for bacterial clearance and disease severity
por: Maseko, Thando Glory, et al.
Publicado: (2023)

Moxifloxacin resistance in the F15/LAM4/KZN extensively drug-resistant strain of Mycobacterium tuberculosis
por: Dookie, Navisha, et al.
Publicado: (2014)

Mechanisms of first-line antimicrobial resistance in multi-drug and extensively drug resistant strains of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa
por: Dookie, Navisha, et al.
Publicado: (2016)

HIV-Associated Tuberculosis
por: Naidoo, Kogieleum, et al.
Publicado: (2011)

TB epidemiology: where are the young women? Know your tuberculosis epidemic, know your response
por: Perumal, Rubeshan, et al.
Publicado: (2018)

Understanding the Profile of Tuberculosis and Human Immunodeficiency Virus Coinfection: Insights from Expanded HIV Surveillance at a Tuberculosis Facility in Durban, South Africa
por: Perumal, Rubeshan, et al.
Publicado: (2014)

Detection of differentially culturable tubercle bacteria in sputum from drug-resistant tuberculosis patients
por: Gordhan, Bhavna G., et al.
Publicado: (2022)

Plasma Biomarkers of Risk of Tuberculosis Recurrence in HIV Co-Infected Patients From South Africa
por: Pillay, Kimesha, et al.
Publicado: (2021)

Tuberculosis: treatment failure, or failure to treat? Lessons from India and South Africa
por: Padayatchi, Nesri, et al.
Publicado: (2019)

Discordant line probe genotypic testing vs culture-based drug susceptibility phenotypic testing in TB endemic KwaZulu-Natal: Impact on bedside clinical decision making
por: Mahomed, Sharana, et al.
Publicado: (2020)

Hyperbilirubinemia in atazanavir-treated human immunodeficiency virus-infected patients: the impact of the UGT1A1*28 allele
por: Naidoo, Anushka, et al.
Publicado: (2017)

Quality of TB care among people living with HIV: Gaps and solutions
por: Naidoo, Kogieleum, et al.
Publicado: (2019)

Rifampicin Mono-Resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: A Significant Phenomenon in a High Prevalence TB-HIV Region
por: Coovadia, Yacoob Mahomed, et al.
Publicado: (2013)

Recurrent Subclinical Tuberculosis Among Antiretroviral Therapy–Accessing Participants: Incidence, Clinical Course, and Outcomes( )
por: Naidoo, Kogieleum, et al.
Publicado: (2022)

Rapid Molecular Assays for the Diagnosis of Drug-Resistant Tuberculosis
por: Nandlal, Louansha, et al.
Publicado: (2022)

INSTIs for the management of HIV-associated TB (INSIGHT study): a phase 2b study to evaluate the efficacy, safety and pharmacokinetics of a combination of bictegravir, emtricitabine and tenofovir alafenamide fumarate for the treatment of HIV-1 infection in patients with drug-susceptible tuberculosis on a rifampicin-based treatment regimen: a phase 2b open-label randomised controlled trial
por: Naidoo, Anushka, et al.
Publicado: (2022)

Treatment Outcomes for Extensively Drug-Resistant Tuberculosis and HIV Co-infection
por: O’Donnell, Max R., et al.
Publicado: (2013)

Genomic and functional analyses of Mycobacterium tuberculosis strains implicate ald in D-cycloserine resistance
por: Desjardins, Christopher A., et al.
Publicado: (2016)

Mortality in HIV and tuberculosis patients following implementation of integrated HIV-TB treatment: Results from an open-label cluster-randomized trial
por: Naidoo, Kogieleum, et al.
Publicado: (2022)

Organizational contextual factors that predict success of a quality improvement collaborative approach to enhance integrated HIV-tuberculosis services: a sub-study of the Scaling up TB/HIV Integration trial
por: Gengiah, Santhanalakshmi, et al.
Publicado: (2021)

Extensively Drug-Resistant Tuberculosis in Women, KwaZulu-Natal, South Africa
por: O’Donnell, Max R., et al.
Publicado: (2011)

Failure of BACTEC™ MGIT 960™ to detect Mycobacterium tuberculosis complex within a 42-day incubation period
por: Mahomed, Sharana, et al.
Publicado: (2017)

Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patients
por: Nimmo, Camus, et al.
Publicado: (2020)

The contrasting cultures of HIV and tuberculosis care
por: Daftary, Amrita, et al.
Publicado: (2015)

Impact of pretreatment low-abundance HIV-1 drug-resistant variants on virological failure among HIV-1/TB-co-infected individuals
por: Chimukangara, Benjamin, et al.
Publicado: (2020)

Addressing challenges in scaling up TB and HIV treatment integration in rural primary healthcare clinics in South Africa (SUTHI): a cluster randomized controlled trial protocol
por: Naidoo, Kogieleum, et al.
Publicado: (2017)

Correction to: Addressing challenges in scaling up TB and HIV treatment integration in rural primary healthcare clinics in South Africa (SUTHI): a cluster randomized controlled trial protocol
por: Naidoo, Kogieleum, et al.
Publicado: (2019)

A cluster‐randomized controlled trial to improve the quality of integrated HIV‐tuberculosis services in primary healthcareclinics in South Africa
por: Gengiah, Santhanalakshmi, et al.
Publicado: (2021)

Major depression and household food insecurity among individuals with multidrug-resistant tuberculosis (MDR-TB) in South Africa
por: Tomita, Andrew, et al.
Publicado: (2019)

Diversity and evolution of drug resistance mechanisms in Mycobacterium tuberculosis
por: Al-Saeedi, Mashael, et al.
Publicado: (2017)

Evolution of Mycobacterium tuberculosis drug resistance in the genomic era
por: Nimmo, Camus, et al.
Publicado: (2022)

The effect of human immunodeficiency virus infection on adverse events during treatment of drug-resistant tuberculosis: A systematic review and meta-analysis
por: Lazarus, Gilbert, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_keomfeilkb21htga8g1oqg7ibh